Bixiye
P20-26 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4151 - 4160 ee natiijooyinka 4294
Bixiye
P19-26 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
P18-26 Blue Cross Prior Authorization/Notification and Clinical Criteria Updates
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Insulin Pumps - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Bonjesta, Diclegis - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
Insulin Combination Agents (Soliqua, Xultophy) - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Cholestasis Pruritus - Medicaid
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Cholestasis Pruritus - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
QP26-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026